
Neurologist / Neuroimmunologist / Medical Informatics / Health Informatics #NeuroVision #NMOSD #MOGAD #MS #DigitalTransformation #DataIntegration
LMU Hospital / Munich Germany
Joined November 2020
- Tweets185
- Following129
- Followers356
- Likes540
Joachim Havla retweeted

ECTRIMS@ECTRIMS15 Jul 2025
Germany
GermanyConnected via United States App StoreAccount-level information, not a live location or per-post device.
🎓 Webcasts from our Summer School in Stockholm this June are now available on #myECTRIMS! Gain insights from leading experts on Visual System Evaluation in #MS and Other Demyelinating Diseases. Watch them here: bit.ly/3IvdjaH
#ECTRIMSNextGen #MultipleSclerosis
Joachim Havla retweeted
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD
bit.ly/42NTGmc
Joachim Havla retweeted
This new multicentre study of 113 MOGAD patients looked at impact of disease burden on cognition longitudinally. One in 10 patients (11%) showed neuropsychological deficits, which were predicted stronlgly by cerebral lesions
jnnp.bmj.com/content/early/2… @NeuroVisionLab, @pia_sperber
Joachim Havla retweeted
1️⃣ month until TSF’s 7th Annual Gala at the National Aquarium Denmark 🪼🐠🦭🐡
If you’re attending ECTRIMS, join us on September 17th to illuminate #NMOSD & #MOGAD under the sea.
🎟️ Grab your tax-deductible tickets here: eventbrite.com/e/the-sumaira…
Joachim Havla retweeted
This new multicentre study of 113 MOGAD patients looked at impact of disease burden on cognition longitudinally. One in 10 patients (11%) showed neuropsychological deficits, which were predicted stronlgly by cerebral lesions
jnnp.bmj.com/content/early/2… @NeuroVisionLab, @pia_sperber
Joachim Havla retweeted
Conducting a genome-wide CRISPR screen, a team led by Martin Kerschensteiner @Ker_Lab and Naoto Kawakami @KawakamiLab was able to provide a definite molecular characterization of the central step in MS pathogenesis
lmu.de/en/newsroom/news-over…
Joachim Havla retweeted
New work on clinical prediction models: cochranelibrary.com/cdsr/doi…
Some take aways: (1) Models are not ready for clinical use, (2) Most do not appear to be meant for use, (3) There is a disconnect between methods research and clinical research @ulrike_held @HeidiBaya
Joachim Havla retweeted
🌟 Presenting Our Original Article🌟
📚 Inner #Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive #MultipleSclerosis
🔗 mdpi.com/2437676
👨🔬 By Mr. Jonathan Gernert and Dr. Joachim Havla et al.
@MDPIOpenAccess
#Neurobiology
Joachim Havla retweeted
📝#PaperAlert: Fighting #neurological diseases & new possibilities for non-invasive brain health monitoring: @erturklab revealed that immune cells in the skull’s bone marrow are unique in composition & disease response #Alzheimers #MultipleSclerosis
👉t1p.de/av1uw
Joachim Havla retweeted
#ICYMI Wir wurden von Dr. Joachim Havla, Neurologe und #NMOSD/#MOGAD-Spezialist an der Ludwig-Maximilians-Universität München, für das erste Live-Webinar der TSF auf Deutsch begleitet.
youtu.be/bqKr1-RCBiM
@NeuroVisionLab @WIR_UND_NMO @LMU_Muenchen #NeuroTwitter
Joachim Havla retweeted
🇩🇪 Die Sumaira Foundation war beim Auftakt zur Kampagne "Seltene Erkrankungen in Bayern" vertreten. MdB Erich Irlstorfer möchte mehr Aufmerksamkeit für seltene Erkrankungen schaffen. Unterstützt wird er dabei von Eva Luise und Prof. Dr. Horst Köhler. #SelteneErkrankungenBayern
Joachim Havla retweeted
Here it is!! And this is a first. Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society @VukusicS @marignierro #SFSEP and all the Teams #FCRIN4MS journals.sagepub.com/doi/10.….
Joachim Havla retweeted
New Research: Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria: To pave the way for healthy aging in early treated phenylketonuria (ETPKU) patients, a better understanding of… frontiersin.org/articles/10.… #Neurology
Joachim Havla retweeted

ECTRIMS@ECTRIMS30 May 2022
Germany
GermanyConnected via United States App StoreAccount-level information, not a live location or per-post device.
On this #WorldMSDay we pay tribute to #MS researchers worldwide as they work to find better treatment options for people living with multiple sclerosis. We are grateful for your work and will continue to promote & share your advancements and learnings in research
#MSConnections
Joachim Havla retweeted
Are you curious about translational neuroimmunology?
We are looking for a highly motivated PhD student or Post-Doc to join our lab.
Please RT!
bmc.med.uni-muenchen.de/news…
Joachim Havla retweeted
The skull is considered a physical barrier (helmet) for the brain. Our new findings show that the skull can be utilized to interact and monitor neuroinflammation in diverse brain diseases.
#scRNAseq #proteomics #skull #AI #clearing #TSPOPET
biorxiv.org/content/10.1101/… details🧵👇1/n
Joachim Havla retweeted
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody–Seropositive Patients bit.ly/3b8MeXd #Neurology
Joachim Havla retweeted
Finally our new website is online 🤩 Check it out here: neuroimmunology-munich.de/ou…
Joachim Havla retweeted
Neuroimmunology Munich | Gerdes Lab – MS Twin Study. New Year, new webpage !!! 😀 neuroimmunology-munich.de/ou…























